INS and obesity disorder: Our interesting findings regarding improved glucose tolerance and insulin sensitivity after exosome therapy could be attributed to their role in attenuating HFD-induced obesity, primarily through their protective effect on islets by reducing macrophage infiltration and inflammation (Chen W. et al., 2016).